Skip to main page content
U.S. flag

An official website of the United States government

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Search Results

472 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Efficacy and safety of once-weekly semaglutide versus once-daily insulin glargine as add-on to metformin (with or without sulfonylureas) in insulin-naive patients with type 2 diabetes (SUSTAIN 4): a randomised, open-label, parallel-group, multicentre, multinational, phase 3a trial.
Aroda VR, Bain SC, Cariou B, Piletič M, Rose L, Axelsen M, Rowe E, DeVries JH. Aroda VR, et al. Among authors: rowe e. Lancet Diabetes Endocrinol. 2017 May;5(5):355-366. doi: 10.1016/S2213-8587(17)30085-2. Epub 2017 Mar 23. Lancet Diabetes Endocrinol. 2017. PMID: 28344112 Clinical Trial.
Similar risk of exercise-related hypoglycaemia for insulin degludec to that for insulin glargine in patients with type 1 diabetes: a randomized cross-over trial.
Heise T, Bain SC, Bracken RM, Zijlstra E, Nosek L, Stender-Petersen K, Rabøl R, Rowe E, Haahr HL. Heise T, et al. Among authors: rowe e. Diabetes Obes Metab. 2016 Feb;18(2):196-9. doi: 10.1111/dom.12588. Epub 2015 Nov 27. Diabetes Obes Metab. 2016. PMID: 26450456 Free PMC article. Clinical Trial.
Plasma pentazocine radioimmunoassay.
Peterson JE, Graham M, Banks WF, Benziger D, Rowe EA, Clemans S, Edelson J. Peterson JE, et al. Among authors: rowe ea. J Pharm Sci. 1979 May;68(5):626-8. doi: 10.1002/jps.2600680530. J Pharm Sci. 1979. PMID: 430503
Nail Disorders as clues to systemic disease.
Rowe E, Zubek AE. Rowe E, et al. Clin Dermatol. 2024 Dec 16:S0738-081X(24)00278-5. doi: 10.1016/j.clindermatol.2024.12.013. Online ahead of print. Clin Dermatol. 2024. PMID: 39694199
472 results